Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice-based clinical trial.
Pediatr Allergy Immunol
; 35(4): e14115, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38566365
ABSTRACT
BACKGROUND:
Introducing peanut products early can prevent peanut allergy (PA). The "Addendum guidelines for the prevention of PA in the United States" (PPA guidelines) recommend early introduction of peanut products to low and moderate risk infants and evaluation prior to starting peanut products for infants at high risk for PA (those with severe eczema and/or egg allergy). Rapid adoption of guidelines could aid in lowering the prevalence of PA. The Intervention to Reduce Early (Peanut) Allergy in Children (iREACH) trial was designed to promote PPA guideline adherence by pediatric clinicians.METHODS:
A two-arm, cluster-randomized, controlled clinical trial was designed to measure the effectiveness of an intervention that included clinician education and accompanying clinical decision support tools integrated in electronic health records (EHR) versus standard care. Randomization was at the practice level (n = 30). Primary aims evaluated over an 18-month trial period assess adherence to the PPA guidelines using EHR documentation at 4- and 6-month well-child care visits aided by natural language processing. A secondary aim will evaluate the effectiveness in decreasing the incidence of PA by age 2.5 years using EHR documentation and caregiver surveys. The unit of observation for evaluations are individual children with clustering at the practice level.CONCLUSION:
Application of this intervention has the potential to inform the development of strategies to speed implementation of PPA guidelines.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Egg Hypersensitivity
/
Peanut Hypersensitivity
Limits:
Child
/
Child, preschool
/
Humans
/
Infant
Country/Region as subject:
America do norte
Language:
En
Journal:
Pediatr Allergy Immunol
/
Pediatr. allergy immunol
/
Pediatric allergy and immunology
Journal subject:
ALERGIA E IMUNOLOGIA
/
PEDIATRIA
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido